AkzoNobel (AKZOY)
(Delayed Data from OTC)
$21.74 USD
-0.62 (-2.77%)
Updated Sep 20, 2024 04:00 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Cash flow Statements
Fiscal Year End for Akzo Nobel NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 528.16 | 408.80 | 1,016.28 | 774.48 | 621.60 |
Depreciation/Amortization & Depletion | 386.38 | 387.72 | 415.27 | 412.37 | 403.20 |
Net Change from Assets/Liabilities | 232.69 | -311.87 | -515.83 | 244.45 | -791.84 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 71.43 | -207.56 | -199.94 | -37.70 | -196.00 |
Net Cash From Operating Activities | 1,218.67 | 277.10 | 715.78 | 1,393.61 | 36.96 |
Property & Equipment | -309.54 | -307.65 | -340.73 | -294.71 | -239.68 |
Acquisition/ Disposition of Subsidiaries | -19.48 | -581.59 | -60.34 | -93.67 | -134.40 |
Investments | 84.42 | -291.85 | 225.97 | -127.94 | 5,978.56 |
Other Investing Activities | 88.75 | 27.39 | 16.56 | 28.56 | 8.96 |
Net Cash from Investing Activities | -155.85 | -1,153.69 | -158.54 | -487.76 | 5,613.44 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | -704.86 | -1,342.82 | -633.98 | -5,062.40 |
Issuance (Repayment) of Debt | -496.78 | 2,306.33 | 654.25 | 720.79 | -686.56 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -398.29 | -399.31 | -462.59 | -439.79 | -1,619.52 |
Other Financing Activities | 0.00 | 0.00 | -1.18 | -50.26 | 0.00 |
Net Cash from Financing Activities | -895.06 | 1,202.16 | -1,152.34 | -403.23 | -7,368.48 |
Effect of Exchange Rate Changes | -108.23 | -24.23 | 41.41 | -78.82 | 13.44 |
Net Change In Cash & Equivalents | 59.53 | 301.33 | -554.87 | 423.79 | -1,704.64 |
Cash at Beginning of Period | 1,513.06 | 1,171.60 | 1,870.48 | 1,382.18 | 3,059.84 |
Cash at End of Period | 1,572.58 | 1,472.93 | 1,315.61 | 1,805.98 | 1,355.20 |
Diluted Net EPS | 0.93 | 0.71 | 1.76 | 1.25 | 0.94 |
Fiscal Year End for Akzo Nobel NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | 528.16 | 475.63 | 260.61 |
Depreciation/Amortization & Depletion | NA | NA | 386.38 | 287.34 | 190.82 |
Net Change from Assets/Liabilities | NA | NA | 232.69 | -152.38 | -183.19 |
Net Cash from Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | NA | 71.43 | -9.80 | 9.81 |
Net Cash From Operating Activities | NA | NA | 1,218.67 | 600.80 | 278.05 |
Property & Equipment | NA | NA | -309.54 | -187.20 | -128.67 |
Acquisition/ Disposition of Subsidiaries | NA | NA | -19.48 | -15.24 | -42.53 |
Investments | NA | NA | 84.42 | 116.46 | 114.49 |
Other Investing Activities | NA | NA | 88.75 | 51.15 | 27.26 |
Net Cash from Investing Activities | NA | NA | -155.85 | -34.83 | -29.44 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | NA | -496.78 | 14.15 | 141.75 |
Increase (Decrease) Short-Term Debt | NA | NA | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | NA | -398.29 | -313.46 | -296.59 |
Other Financing Activities | NA | NA | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | NA | -895.06 | -299.31 | -154.84 |
Effect of Exchange Rate Changes | NA | NA | -108.23 | -35.92 | -35.98 |
Net Change In Cash & Equivalents | NA | NA | 59.53 | 230.74 | 57.79 |
Cash at Beginning of Period | NA | NA | 1,513.06 | 1,521.58 | 1,524.38 |
Cash at End of Period | NA | NA | 1,572.58 | 1,752.32 | 1,582.17 |
Diluted Net EPS | 0.37 | 0.20 | 0.08 | 0.40 | 0.25 |